Who owns COYA THERAPEUTICS INC?
- Ticker: COYA
- CUSIP Number: 22407b108
Tip: Access positions for across all investors
Analyze quarterly positions in Coya Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Coya Therapeutics stock
Who bought or sold COYA THERAPEUTICS INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
DME Capital Management | 1.3M | $13M | 100% | Mar 2024 |
|
Greenlight Capital | 1.3M | $9.4M | 172% | Dec 2023 |
|
Vanguard Group | 848k | $8.4M | 772% | Mar 2024 |
|
AIGH Capital Management | 649k | $6.4M | -37% | Mar 2024 |
|
Geode Capital Management | 126k | $1.3M | 45% | Mar 2024 |
|
Raymond James & Associates | 110k | $1.1M | 100% | Mar 2024 |
|
CM Management | 100k | $992k | 0% | Mar 2024 |
|
BlackRock | 54k | $536k | 145% | Mar 2024 |
|
Springbok Capital Management | 36k | $355k | 0% | Mar 2024 |
|
Royal Bank of Canada | 32k | $0 | 14951% | Mar 2024 |
|
Northern Trust | 26k | $253k | 100% | Mar 2024 |
|
Potomac Capital Management | 21k | $156k | 100% | Dec 2023 |
|
Jane Street | 20k | $199k | 100% | Mar 2024 |
|
Mirador Capital Partners | 16k | $154k | -4% | Mar 2024 |
|
Bank of America Corporation | 1.6k | $16k | 16150% | Mar 2024 |
|
UBS Group | 600.00 | $6.0k | -76% | Mar 2024 |
|
Morgan Stanley | 532.00 | $5.3k | 6% | Mar 2024 |
|
Jpmorgan Chase & Co | 530.00 | $5.3k | 715% | Mar 2024 |
|
Tucker Asset Management | 200.00 | $1.5k | 100% | Dec 2023 |
|
Wells Fargo & Company | 100.00 | $992.000000 | 54% | Mar 2024 |
|
Who sold out of Coya Therapeutics?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Worth Venture Partners | Dec 2023 | 93k | $687k |
Citadel Advisors | Dec 2023 | 17k | $123k |
Tower Research Capital | Sep 2023 | 2.1k | $8.1k |
Tradition Wealth Management | Dec 2023 | 849.00 | $6.0k |